PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	184-187	estrogen receptor 1	Homo sapiens	66-83	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	184-187	estrogen receptor 1	Homo sapiens	85-92	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	184-187	estrogen receptor 1	Homo sapiens	94-100	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	184-187	estrogen receptor 1	Homo sapiens	268-274	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	230-233	estrogen receptor 1	Homo sapiens	66-83	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	230-233	estrogen receptor 1	Homo sapiens	85-92	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	230-233	estrogen receptor 1	Homo sapiens	94-100	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	230-233	estrogen receptor 1	Homo sapiens	259-266	
34486460-6	2021	Additionally, our results considered that androgen receptor (AR), estrogen receptor (ERalpha, ERbeta), and NFKB1 gene expressions exhibited up-regulation in HPEpiC treated with 10-9 M BPA for 72 h. However, in HPrF, the identical BPA treatment could activate ERalpha, ERbeta, and NFKB1 gene expressions and down-regulated the expression of AR levels.	bisphenol A	230-233	estrogen receptor 1	Homo sapiens	268-274